Bio-Rad Laboratories Revenue 2006-2019 | BIO.B

Bio-Rad Laboratories annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Bio-Rad Laboratories revenue for the quarter ending September 30, 2019 was $0.561B, a 2.84% increase year-over-year.
  • Bio-Rad Laboratories revenue for the twelve months ending September 30, 2019 was $2.304B, a 0.45% increase year-over-year.
  • Bio-Rad Laboratories annual revenue for 2018 was $2.289B, a 5.98% increase from 2017.
  • Bio-Rad Laboratories annual revenue for 2017 was $2.16B, a 4.45% increase from 2016.
  • Bio-Rad Laboratories annual revenue for 2016 was $2.068B, a 2.41% increase from 2015.
Bio-Rad Laboratories Annual Revenue
(Millions of US $)
2018 $2,289
2017 $2,160
2016 $2,068
2015 $2,019
2014 $2,175
2013 $2,133
2012 $2,069
2011 $2,074
2010 $1,927
2009 $1,784
2008 $1,764
2007 $1,461
2006 $1,274
2005 $1,181
Bio-Rad Laboratories Quarterly Revenue
(Millions of US $)
Q3 2019 $561
Q2 2019 $573
Q1 2019 $554
Q4 2018 $617
Q3 2018 $545
Q2 2018 $576
Q1 2018 $552
Q4 2017 $621
Q3 2017 $534
Q2 2017 $505
Q1 2017 $500
Q4 2016 $571
Q3 2016 $509
Q2 2016 $517
Q1 2016 $471
Q4 2015 $571
Q3 2015 $470
Q2 2015 $506
Q1 2015 $473
Q4 2014 $598
Q3 2014 $531
Q2 2014 $537
Q1 2014 $509
Q4 2013 $603
Q3 2013 $505
Q2 2013 $525
Q1 2013 $500
Q4 2012 $574
Q3 2012 $499
Q2 2012 $510
Q1 2012 $486
Q4 2011 $550
Q3 2011 $517
Q2 2011 $522
Q1 2011 $485
Q4 2010 $534
Q3 2010 $472
Q2 2010 $468
Q1 2010 $454
Q4 2009 $495
Q3 2009 $461
Q2 2009 $427
Q1 2009 $401
Q4 2008 $448
Q3 2008 $442
Q2 2008 $452
Q1 2008 $422
Q4 2007 $460
Q3 2007 $340
Q2 2007 $339
Q1 2007 $323
Q4 2006 $343
Q3 2006 $305
Q2 2006 $318
Q1 2006 $308
Q4 2005 $307
Q3 2005 $283
Q2 2005 $291
Q1 2005 $299
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $10.822B $2.290B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $140.667B 16.20
CSL (CSLLY) Australia $87.267B 0.00
Gilead Sciences (GILD) United States $83.209B 10.31
Vertex Pharmaceuticals (VRTX) United States $56.311B 57.47
Biogen (BIIB) United States $53.561B 9.19
Illumina (ILMN) United States $47.734B 52.37
Regeneron Pharmaceuticals (REGN) United States $41.329B 18.10
Alexion Pharmaceuticals (ALXN) United States $24.435B 12.07
Incyte (INCY) United States $19.711B 45.76
Seattle Genetics (SGEN) United States $19.516B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $16.617B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.401B 0.00
Genmab (GNMSF) Denmark $13.473B 59.51
Alnylam Pharmaceuticals (ALNY) United States $13.127B 0.00
Galapagos (GLPG) Belgium $11.469B 29.55
Exact Sciences (EXAS) United States $11.321B 0.00
Sarepta Therapeutics (SRPT) United States $9.843B 0.00
QIAGEN (QGEN) Netherlands $9.282B 30.26
Amarin (AMRN) Ireland $8.616B 0.00
BeiGene (BGNE) Cayman Islands $8.453B 0.00
Bio-Techne Corp (TECH) United States $8.119B 54.34
BioNTech SE (BNTX) Germany $7.342B 0.00
Guardant Health (GH) United States $7.127B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.829B 0.00
Medicines (MDCO) United States $6.714B 0.00
Reata Pharmaceuticals (RETA) United States $6.259B 0.00
Moderna (MRNA) United States $6.205B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.151B 15.64
ARGENX SE-ADR (ARGX) Netherlands $5.987B 0.00
Exelixis (EXEL) United States $5.415B 15.23
Bluebird Bio (BLUE) United States $4.966B 0.00
Ascendis Pharma (ASND) Denmark $4.854B 0.00
Repligen (RGEN) United States $4.612B 83.58
China Biologic Products (CBPO) China $4.605B 25.94
MorphoSys AG (MOR) Germany $4.485B 0.00
Mirati Therapeutics (MRTX) United States $4.427B 0.00
Spark Therapeutics (ONCE) United States $4.266B 0.00
Immunomedics (IMMU) United States $3.997B 0.00
Adaptive Biotechnologies (ADPT) United States $3.755B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.737B 0.00
Blueprint Medicines (BPMC) United States $3.653B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.608B 0.00
Alkermes (ALKS) Ireland $3.287B 0.00
UniQure (QURE) Netherlands $3.227B 0.00
MyoKardia (MYOK) United States $3.083B 0.00
Genmab (GMAB) Denmark $2.854B 5.88
Halozyme Therapeutics (HALO) United States $2.781B 0.00
NeoGenomics (NEO) United States $2.758B 146.78
Emergent Biosolutions (EBS) United States $2.683B 26.65
Acceleron Pharma (XLRN) United States $2.679B 0.00
Zai Lab (ZLAB) China $2.502B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.469B 0.00
Amicus Therapeutics (FOLD) United States $2.403B 0.00
Arena Pharmaceuticals (ARNA) United States $2.356B 5.48
RA PHARMCTL INC (RARX) United States $2.225B 0.00
Insmed (INSM) United States $2.074B 0.00
Myriad Genetics (MYGN) United States $1.903B 28.11
Ligand Pharmaceuticals (LGND) United States $1.862B 35.82
Dicerna Pharmaceuticals (DRNA) United States $1.833B 0.00
Denali Therapeutics (DNLI) United States $1.815B 0.00
Akcea Therapeutics (AKCA) United States $1.812B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.656B 0.00
Zymeworks (ZYME) Canada $1.654B 0.00
Principia Biopharma (PRNB) United States $1.630B 0.00
Epizyme (EPZM) United States $1.613B 0.00
REGENXBIO (RGNX) United States $1.606B 0.00
Editas Medicine (EDIT) United States $1.534B 0.00
Arvinas (ARVN) United States $1.435B 0.00
Fate Therapeutics (FATE) United States $1.420B 0.00
Innoviva (INVA) United States $1.394B 4.11
Alector (ALEC) United States $1.393B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.371B 0.00
Coherus BioSciences (CHRS) United States $1.299B 0.00
WAVE Life Sciences (WVE) Singapore $1.289B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.188B 0.00
Zealand Pharma (ZLDPF) Denmark $1.129B 0.00
Athenex (ATNX) United States $1.128B 0.00
Zealand Pharma (ZEAL) Denmark $1.015B 0.00
Pharming Group (PHGUF) Netherlands $1.013B 0.00
Sangamo Therapeutics (SGMO) United States $0.987B 0.00
Codexis (CDXS) United States $0.925B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.892B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.892B 7.50
Achillion Pharmaceuticals (ACHN) United States $0.877B 0.00
Twist Bioscience (TWST) United States $0.870B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.841B 0.00
Intellia Therapeutics (NTLA) United States $0.807B 0.00
Vericel (VCEL) United States $0.788B 294.00
MiMedx (MDXG) United States $0.782B 0.00
DBV Technologies S.A (DBVT) France $0.780B 0.00
Anika Therapeutics (ANIK) United States $0.758B 24.61
ANI Pharmaceuticals (ANIP) United States $0.739B 12.60
Heska (HSKA) United States $0.732B 186.92
Revance Therapeutics (RVNC) United States $0.721B 0.00
Intra-Cellular Therapies (ITCI) United States $0.709B 0.00
Clovis Oncology (CLVS) United States $0.705B 0.00
Adverum Biotechnologies (ADVM) United States $0.681B 0.00
Cellectis S.A (CLLS) France $0.677B 0.00
UROGEN PHARMA (URGN) United States $0.676B 0.00
Mesoblast (MESO) Australia $0.670B 0.00
Sorrento Therapeutics (SRNE) United States $0.670B 0.00
Cara Therapeutics (CARA) United States $0.663B 0.00
Cytokineticsorporated (CYTK) United States $0.629B 0.00
GENFIT S.A (GNFT) France $0.628B 0.00
Retrophin (RTRX) United States $0.616B 0.00
Kadmon Holdings (KDMN) United States $0.613B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.590B 0.00
PHARMA MAR SA (PHMMF) Spain $0.584B 0.00
Dynavax Technologies (DVAX) United States $0.580B 0.00
AC Immune SA (ACIU) Switzerland $0.577B 13.34
BioDelivery Sciences (BDSI) United States $0.573B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.540B 0.00
Agenus (AGEN) United States $0.527B 0.00
Precision BioSciences (DTIL) United States $0.523B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.516B 3.57
Prothena (PRTA) Ireland $0.513B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.508B 0.00
Stemline Therapeutics (STML) United States $0.504B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
AnaptysBio (ANAB) United States $0.427B 0.00
Avid Bioservices (CDMO) United States $0.410B 0.00
Arcus Biosciences (RCUS) United States $0.397B 0.00
Merus (MRUS) Netherlands $0.395B 0.00
Bellus Health (BLU) Canada $0.387B 0.00
PDL BioPharma (PDLI) United States $0.384B 9.60
AMAG Pharmaceuticals (AMAG) United States $0.378B 0.00
OSMOTICA PHARM (OSMT) United States $0.370B 0.00
Puma Biotechnology (PBYI) United States $0.365B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.344B 0.00
Gritstone Oncology (GRTS) United States $0.331B 0.00
Starpharma Holdings (SPHRY) Australia $0.327B 0.00
CytomX Therapeutics (CTMX) United States $0.325B 0.00
Cellular Biomedicine (CBMG) United States $0.321B 0.00
Kindred Biosciences (KIN) United States $0.319B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.314B 0.00
Cue Biopharma (CUE) United States $0.312B 0.00
Scholar Rock Holding (SRRK) United States $0.305B 0.00
Geron (GERN) United States $0.300B 0.00
Seres Therapeutics (MCRB) United States $0.294B 0.00
Kamada (KMDA) Israel $0.294B 8.58
Compugen (CGEN) Israel $0.290B 0.00
NantKwest (NK) United States $0.283B 0.00
MannKind (MNKD) United States $0.279B 0.00
ChromaDex (CDXC) United States $0.275B 0.00
Inovio Pharmaceuticals (INO) United States $0.272B 0.00
Exicure (XCUR) United States $0.261B 0.00
Sutro Biopharma (STRO) United States $0.257B 0.00
Albireo Pharma (ALBO) United States $0.257B 0.00
IVERIC Bio (ISEE) United States $0.246B 0.00
ADMA Biologics Inc (ADMA) United States $0.242B 0.00
Senesco Technologies (ELOX) United States $0.239B 0.00
Theratechnologies (THTX) Canada $0.234B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.231B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.227B 0.00
Biofrontera AG (BFRA) Germany $0.221B 0.00
Proteostasis Therapeutics (PTI) United States $0.217B 0.00
Spero Therapeutics (SPRO) United States $0.212B 0.00
XOMA (XOMA) United States $0.208B 0.00
POXEL SA FRANCE (PXXLF) France $0.203B 0.00
Protagonist Therapeutics (PTGX) United States $0.199B 0.00
Syros Pharmaceuticals (SYRS) United States $0.195B 0.00
Cerecor (CERC) United States $0.195B 0.00
Affimed (AFMD) Germany $0.194B 0.00
Athersys (ATHX) United States $0.194B 0.00
ARAVIVE, INC (ARAV) United States $0.190B 0.00
Abeona Therapeutics (ABEO) United States $0.187B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.181B 0.00
Mersana Therapeutics (MRSN) United States $0.178B 0.00
VBI Vaccines (VBIV) United States $0.174B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.162B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.158B 0.00
Five Prime Therapeutics (FPRX) United States $0.157B 0.00
Dyadic (DYAI) United States $0.153B 0.00
Windtree Therapeutics (WINT) United States $0.151B 0.00
Alcobra (ARCT) United States $0.150B 0.00
Aptinyx (APTX) United States $0.143B 0.00
Fortress Biotech (FBIO) United States $0.139B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.138B 0.00
Arsanis (XFOR) United States $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Prometic Life Sciences (LMNL) Canada $0.134B 0.00
Northwest Biotherapeutics (NWBO) United States $0.133B 0.00
Arbutus Biopharma (ABUS) Canada $0.132B 0.00
TELA Bio (TELA) United States $0.128B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.128B 0.00
Nicox SA (NICXF) France $0.125B 0.00
Enzo Biochem (ENZ) United States $0.125B 0.00
SESEN BIO, INC (SESN) United States $0.115B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.109B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.108B 0.00
Novavax (NVAX) United States $0.107B 0.00
Menlo Therapeutics (MNLO) United States $0.105B 0.00
Celyad SA (CYAD) Belgium $0.102B 0.00
Emmaus Life Sciences (EMMA) United States $0.101B 0.00
Strongbridge Biopharma (SBBP) United States $0.100B 2.67
Verastem (VSTM) United States $0.100B 0.00
PHASEBIO PHARMA (PHAS) United States $0.097B 0.00
Aduro Biotech (ADRO) United States $0.090B 0.00
Antibe Therapeutics (ATBPF) Canada $0.089B 0.00
Adocia (ADOCY) France $0.086B 0.00
Acorda Therapeutics (ACOR) United States $0.085B 0.00
VTv Therapeutics (VTVT) United States $0.083B 0.00
OvaScience (MLND) United States $0.083B 0.00
Vaccinex (VCNX) United States $0.082B 0.00
Synlogic (SYBX) United States $0.077B 0.00
Clearside Biomedical (CLSD) United States $0.074B 0.00
Selecta Biosciences (SELB) United States $0.074B 0.00
Trevena (TRVN) United States $0.069B 0.00
Liquidia Technologies (LQDA) United States $0.068B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.066B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.066B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.066B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.065B 0.00
Organovo Holdings (ONVO) United States $0.065B 0.00
NewLink Genetics (NLNK) United States $0.061B 0.00
Catalyst Biosciences (CBIO) United States $0.059B 0.00
Pluristem Therapeutics (PSTI) Israel $0.054B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.051B 0.00
AIT Therapeutics (XAIR) United States $0.051B 0.00
Curis (CRIS) United States $0.050B 0.00
Applied Genetic Technologies (AGTC) United States $0.050B 0.00
Checkpoint Therapeutics (CKPT) United States $0.049B 0.00
Idera Pharmaceuticals (IDRA) United States $0.046B 0.00
Orgenesis (ORGS) United States $0.046B 2.97
DiaMedica Therapeutics (DMAC) United States $0.045B 0.00
AquaBounty Technologies (AQB) United States $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.044B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.041B 0.00
Alimera Sciences (ALIM) United States $0.041B 0.00
Celsion (CLSN) United States $0.037B 0.00
Evogene (EVGN) Israel $0.036B 0.00
Oncobiologics (OTLK) United States $0.035B 0.00
Celldex Therapeutics (CLDX) United States $0.035B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.035B 0.00
Stellar Biotechnologies (EDSA) Canada $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.030B 0.00
Apricus Biosciences (SEEL) United States $0.030B 0.00
VIVUS (VVUS) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.67
BioCardia (BCDA) United States $0.028B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.027B 0.00
Bionano Genomics (BNGO) United States $0.027B 0.00
Novogen (KZIA) Australia $0.027B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
Soligenix (SNGX) United States $0.026B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
Entera Bio (ENTX) Israel $0.026B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.023B 0.00
CollPlant Holdings (CLGN) Israel $0.021B 0.00
Signal Genetics (MGEN) United States $0.020B 0.00
Aytu Bioscience (AYTU) United States $0.019B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Unum Therapeutics (UMRX) United States $0.016B 0.00
AEterna Zentaris (AEZS) United States $0.016B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
Advaxis (ADXS) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.011B 0.00
TrovaGene (TROV) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
TRACON Pharmaceuticals (TCON) United States $0.008B 0.00
Cesca Therapeutics (THMO) United States $0.008B 0.00
Cleveland BioLabs (CBLI) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.003B 0.00